Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-(2-(4-methylbenzylidene)hydrazinyl)-N-(2-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-5-amine | 64% inhibition at 0.05 mM, 35% inhibition at 0.005 mM | Mycobacterium tuberculosis | |
3-(2-(4-methylbenzylidene)hydrazinyl)-N-(4-nitrophenyl)-1,2,4-thiadiazol-5-amine | 8% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-(4-methylbenzylidene)hydrazinyl)-N-(p-tolyl)-1,2,4-thiadiazol-5-amine | 21% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-(4-methylbenzylidene)hydrazinyl)-N-phenyl-1,2,4-thiadiazol-5-amine | 34% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(2,4-dichlorophenyl)-1,2,4-thiadiazol-5-amine | 38% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(2-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-5-amine | 50% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(4-bromophenyl)-1,2,4-thiadiazol-5-amine | 61% inhibition at 0.05 mM, 39% inhibition at 0.005 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(4-fluorophenyl)-1,2,4-thiadiazol-5-amine | 54% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(4-iodophenyl)-1,2,4-thiadiazol-5-amine | - |
Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(4-methoxyphenyl)-1,2,4-thiadiazol-5-amine | 46% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(4-nitrophenyl)-1,2,4-thiadiazol-5-amine | 35% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-(p-tolyl)-1,2,4-thiadiazol-5-amine | 75% inhibition at 0.05 mM, 48% inhibition at 0.005 mM | Mycobacterium tuberculosis | |
3-(2-benzylidenehydrazinyl)-N-phenyl-1,2,4-thiadiazol-5-amine | 16% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
cefozopran | - |
Mycobacterium tuberculosis | |
ciprofloxacine | - |
Mycobacterium tuberculosis | |
ethambutol | - |
Mycobacterium tuberculosis | |
isoniazid | - |
Mycobacterium tuberculosis | |
N-(2,4-dichlorophenyl)-3-(2-(4-methylbenzylidene)hydrazinyl)-1,2,4-thiadiazol-5-amine | 62% inhibition at 0.05 mM, 48% inhibition at 0.005 mM | Mycobacterium tuberculosis | |
N-(4-bromophenyl)-3-(2-(4-methylbenzylidene)hydrazinyl)-1,2,4-thiadiazol-5-amine | 46% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
N-(4-fluorophenyl)-3-(2-(4-methylbenzylidene)hydrazinyl)-1,2,4-thiadiazol-5-amine | 67% inhibition at 0.05 mM, 26% inhibition at 0.005 mM | Mycobacterium tuberculosis | |
N-(4-iodophenyl)-3-(2-(4-methylbenzylidene)hydrazinyl)-1,2,4-thiadiazol-5-amine | 34% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
N-(4-methoxyphenyl)-3-(2-(4-methylbenzylidene)hydrazinyl)-1,2,4-thiadiazol-5-amine | 50% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
Pyrazinamide | - |
Mycobacterium tuberculosis | |
rifampicin | - |
Mycobacterium tuberculosis | |
triclosan | more than 99% inhibition at 0.05 mM | Mycobacterium tuberculosis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | - |
- |
- |
Mycobacterium tuberculosis H37Rv | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
trans-2-dodecenoyl-CoA + NADH + H+ | - |
Mycobacterium tuberculosis | dodecanoyl-CoA + NAD+ | - |
? | |
trans-2-dodecenoyl-CoA + NADH + H+ | - |
Mycobacterium tuberculosis H37Rv | dodecanoyl-CoA + NAD+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
enoyl acyl carrier protein reductase | - |
Mycobacterium tuberculosis |
InhA | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | - |
Mycobacterium tuberculosis |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.05 | - |
at pH 6.8 and 25°C | Mycobacterium tuberculosis | 3-(2-benzylidenehydrazinyl)-N-(2-(trifluoromethyl)phenyl)-1,2,4-thiadiazol-5-amine | |
0.05 | - |
at pH 6.8 and 25°C | Mycobacterium tuberculosis | N-(4-methoxyphenyl)-3-(2-(4-methylbenzylidene)hydrazinyl)-1,2,4-thiadiazol-5-amine |